sage rests heavily sage-217 experimental drug company pipeline works way zulresso taken daily pill sage-217 worth billions dollars approved postpartum depression larger commercially lucrative treatment major depressive disorder january sage announced phase 3 study sage-217 women postpartum depression phase 3 study sage-217 major depressive disorder underway hoping confirm benefit seen stifel matteis said goes right sage-217 win fda approval 2021 stat delivers fast deep tough minded journalism inside science labs hospitals biotech boardrooms political backrooms dissect crucial discoveries examine controversies puncture hype hold individuals institutions accountable introduce power brokers personalities driving revolution human health stories matter august 15 2018 dana